Therefore, these findings suggest that dysregulation of the HPA axis in depression is partially attributable to an imbalance between GR and MR suggesting MR is a promising approach to improve antidepressant treatment in TRD (60). The gene discussed is NR3C1; the disease is major depressive disorder.